国产欧美日韩三级_歐美日韓精品一區二區三區視頻播放_成年黄页网站大全免费无码_国产乱伦自拍无码_波野多结衣一区二区三区尤物视频_色综合久久婷婷_午夜一级**片不卡_7080理论片午夜电影在线_日韩少妇人妻中文视频_亚洲A色在线视频

致力于開發(fā)具有戰(zhàn)略優(yōu)勢的創(chuàng)新遞送技術(shù)

Innovation for Best RNA Drugs

多年小核酸平臺(tái)技術(shù)研發(fā)和醫(yī)藥管線開發(fā)經(jīng)驗(yàn)

Innovation for Best RNA Drugs

實(shí)現(xiàn)核酸藥物精確遞送

Innovation for Best RNA Drugs

Overview of siRNA

SiranBio was established in May 2022 in Suzhou Industrial Park. We are a biotech company specialized in siRNA drug development. Our core team is consisted of top scientists and pioneers of siRNA drugs in China. Several prestigious awards has been given to our company since its inception, such as The Leading Enterprise in Suzhou Industrial Park and as Gusu Leading Enterprise in 2002.

"

We have developed comprehensive and proprietary platform technologies which encompass the whole process of siRNA drug development, including siRNA sequence design and screening, chemical modifications for PD enhancement and off-target attenuation (eSAFE), liver and extrahepatic delivery (STORK), and dual-targeting siRNA. Based on these innovative technologies, we very quickly established a robust pipeline with potentials to become First-in-Class (FIC) and Best-in-Class (BIC) siRNA therapeutics for several important therapeutic areas, including anti-viral, cardiovascular and metabolic diseases, autoimmune diseases, CNS diseases.
We always put the patients’ needs in the highest priority, to innovate best siRNA drugs for the health and well-being of human kind.

LEARN MORE

Overview of siRNA

Small interfering RNAs (siRNAs) are short double-strand RNA molecues less than 30 nt long...

SiranBio's Drug Discovery Platforms

SiranBio developed comprehensive, cutting-edge and proprietary platform technologies for siRNA drug discovery...

Corporate History

Nov 2022: Awarded as The Leading Enterprise of Suzhou

News

[2024EASL]: Siran Bio Presents Core Data on Functional Cure of Anti-PD-L1 siRNA Pipeline SA012

Siran Bio Presents at CRT2024 Conference in the US - Sharing Research Findings on SA016, a New Antihypertensive siRNA Drug